![]() |
|
|
Vol. 27, Issue 3, 336-341, March 1999
Department of Pharmaceutical Sciences,
| |
Abstract |
|---|
|
|
|---|
The zonal uptake of estrone sulfate (E1S; 1 to 400 µM) was investigated in periportal and perivenous rat hepatocytes and
cells isolated from whole liver (regular hepatocytes). Transport of E1S by periportal, perivenous, and regular hepatocytes was
described by saturable (Kms of 24 to 26 µM
and Vmaxs of 1.8 nmol/min/mg protein) and
nonsaturable components (2.5 to 3.2 µl/min/mg protein) that were not
different among the zonal regions (p > .05, ANOVA). These kinetic constants represented pooled values for the
entire complement of transporters for E1S, including two
known transporters of E1S: Ntcp,
Na+-taurocholate cotransporting polypeptide, and oatp1, the
organic anion transporting polypeptide cloned from rat liver. Uptake of E1S was significantly reduced by estradiol
17
-glucuronide (50 µM) and bumetanide (200 µM), and was
inhibited strongly and competitively by pregnenolone sulfate with an
inhibition constant of 6.7 µM. Further segregation of the kinetic
constants as the sodium-dependent and -independent systems was achieved
through simultaneous fitting of data obtained in the presence and
absence of sodium from parallel hepatocytic uptake studies. For the
periportal, perivenous, and regular hepatocytes, two saturable systems:
a sodium-dependent transport system, characterized by similar
Vmaxs (1.1 to 1.4 nmol/min/mg protein) and
Kms (49 to 55 µM), a sodium-independent
transport system of comparable Vmaxs (0.70 to 0.84 nmol/min/mg protein) and Kms (16 to
22 µM), and a linear clearance of 1.7 to 2.7 µl/min/mg protein
(ANOVA, p > .05) were obtained. The data suggest
that hepatic uptake of E1S involved sodium-dependent and
-independent transporter systems. No heterogeneity in transport was observed.
| |
Introduction |
|---|
|
|
|---|
Estrone sulfate
(E1S)1
serves as a storage form of estrogens in the human circulation and is
used in hormone replacement therapy. It is metabolized primarily in
liver to estrogens such as estrone, estradiol, and estriol. The influx
of E1S into the liver could influence levels of
estrogens in the body. Moreover, the presence of zonal distribution of
transporters in the liver would affect the cellular concentration and
processing of E1S by desulfation or biliary
excretion among zonal cells, thus altering the overall hepatic
clearance. This aspect has been shown to impact drug levels in
simulation studies (Sato et al., 1986
; Hansel and Morris, 1996
; Kwon
and Morris, 1997
).
The hepatic transport of E1S is mediated by the
organic anion transporting polypeptide (oatp1 and oatp2) and the
sodium-dependent taurocholate cotransporting polypeptide (Ntcp), two
recently cloned sinusoidal transporters (Hagenbuch et al., 1991
, 1994
;
Jacquemin et al., 1994
; Noé et al. 1997
). oatp1 and oatp2,
glycoproteins with 12 putative transmembrane domains, exist on the rat
liver sinusoidal membrane (Jacquemin et al., 1994
), the apical membrane of the kidney (Bergwerk et al., 1996
), and the choroid plexus of the
brain (Noé et al., 1997
). The proteins are noted for their transport of bile acids and derivatives, the anionic dye
bromosulfophthalein, ouabain, and anionic estrogen conjugates
(Kullack-Ublick et al., 1994
; Shi et al., 1995
; Bossuyt et al., 1996
;
Kanai et al., 1996
; Noé et al., 1997
; Pang et al., 1998
).
oatp1-mediated transport is sodium independent, bidirectional (Shi et
al., 1995
), energy dependent (Shi et al., 1995
), and possibly involves
bicarbonate (Satlin et al., 1997
) and glutathione (Li et al., 1998
) as
the counter ion. Ntcp, a glycoprotein with seven transmembrane domains, exists on the basolateral membrane of the liver. Ntcp preferentially mediates not only the hepatic uptake of bile acids and derivatives, but
also anions such as E1S and bromosulfophthalein
(Hagenbuch et al., 1991
; Meier et al., 1997
; Schroeder et al., 1998
).
The transport of anions such as the bile acid taurocholate by Ntcp is
electrogenic and is driven by the physiological sodium gradient (Hagenbuch et al., 1991
) with an apparent
Na+-taurocholate stoichiometry of 2:1 (Weinman,
1997
).
Although the nature of transport proteins is known for the uptake of
E1S, there is virtually no information on its
zonal uptake within the liver acinus. Heterogeneity in transport has
been found for various endogenous and exogenous compounds. For example,
the uptake of glutamate (Burger et al., 1989
; Stoll et al., 1991
), taurocholate (Stacey and Klaassen, 1981
), ouabain (Stacey and Klaassen,
1981
), and cysteine (Saiki et al., 1992
) was reported to be greater in
perivenous than in periportal hepatocytes, whereas the
Na+/K+ ATPase activity was
implicated to be lower in the perivenous region (Sillau et al.,
1996
). The intrinsic transport functions of oatp1 and Ntcp for
E1S uptake has not been compared among zonal hepatocytes, although existing immunohistochemical evidence showed a
lack of liver heterogeneity for Ntcp (Stieger et al., 1994
) and for the
mRNA of oatp1 in rat liver (Dubuisson et al., 1996
). The objective of
this study was to examine the heterogeneity in the uptake of
E1S by investigating the intrinsic difference in transport velocity of E1S among periportal and
perivenous hepatocytes, namely, for the sodium-dependent and
-independent uptake of E1S. The uptake of
E1S in the presence of pregnenolone sulfate, a
structural analog, was appraised to study the possible interactions
between the hormonal sulfate conjugates.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
[3H]E1S [ammonium salt,
specific activity (S.A.), 50 Ci/mmol],
[14C]L-glutamic acid (S.A., 250 mCi/mmol), [14C]sucrose (S.A., 6.4 mCi/mmol),
and [3H]sucrose (S.A., 11.9 Ci/mmol) were
purchased from NEN Life Science Products (Boston, MA). Unlabeled
E1S, glutamic acid, bumetanide, estradiol
17
-glucuronide, choline, BSA (Fraction V), and pregnenolone sulfate
were obtained from Sigma Chemical Co. (St. Louis, MO). Collagenase A
(Clostridium histolyticum) was purchased from Boehringer Mannheim (Darmstadt, Germany). Digitonin was obtained from Fluka Chemie
(Buchs, Switzerland). Silicone oil (Fluids 510 and 550) was purchased
from Dow Corning (Mississauga, ON). All other reagents and solvents
were of HPLC grade.
Isolation of Rat Hepatocytes.
Male Sprague-Dawley rats (275-375 g, Charles River Canada, St.
Constant, QC) were used for the preparation of isolated (regular) hepatocytes from whole liver by a previously established method (Hassen
et al., 1996
). Enriched periportal and perivenous hepatocytes were
isolated by the digitonin/collagenase perfusion technique of Lindros
and Pentïlla (1985)
, with modifications. After anesthesia (50 mg pentobarbital/kg, i.p.), the rat liver was perfused via the portal
vein in a single- pass fashion at 25 ml/min for 10 min with a
Ca2+- free buffer [consisting of Hanks buffer,
10 mM HEPES, 0.5 mM EGTA, 4.2 mM NaHCO3, 5 mM
glucose, 0.65% BSA, pregassed with carbogen (95%
O2, 5% CO2), and buffered
to pH 7.2]. The medium was then changed to the digitonin solution
(3.25 mM digitonin, 150 mM NaCl, 6.7 mM KCl, and 50 mM HEPES) as
described by Tosh et al. (1996)
. The digitonin solution was delivered
at a lower perfusion rate of 5.6 ml/min for approximately 35 ± 9 s (n = 8) progradely (flowing into the portal
vein and exiting at the hepatic vein) or 77 ± 13 sec
(n = 8) retrogradely (flowing into the hepatic vein and exiting at the portal vein). The infusion with digitonin was stopped immediately when maximal destruction of selective zonal cells was
visually detected on the surface of the liver: appearance of white
specks for destruction of perivenous cells and rings for destruction of
periportal cells. The digitonin solution remaining in the liver was
flushed out by perfusion with calcium-free buffer in the opposite
direction (12 ml/min) for 2 min, then with collagenase buffer (Hanks
buffer plus 4 mM CaCl2 and 0.06% w/w
collagenase) for 8 min. All other subsequent steps involved were
carried out as described previously (Hassen et al., 1996
). Viability of
the regular and zonal hepatocytes obtained was greater than 90%, as assessed by trypan blue exclusion.
Zonal Cells.
The enrichment of periportal and perivenous cells by the
digitonin/collagenase perfusion method was monitored with alanine aminotransferase with a Sigma diagnostics kit and with glutamine synthetase assayed by a standard UV method (Meister, 1985
); the protein
content was measured by the method of Lowry et al. (1951)
. Because the
uptake of glutamate from blood was shown to be predominantly perivenous
(Burger et al., 1989
; Stoll et al., 1991
), the periportal and
perivenous cells were further differentiated by their ability to
transport glutamate. After preincubation at 37°C for 10 min, hepatocyte suspensions were added to a mixture of unlabeled glutamate, [14C]glutamate and
[3H]sucrose (an extracellular marker) to result
in glutamate concentrations of 1 to 200 µM in 1.6 × 106 cells/ml. Samples (100 µl) retrieved at 30, 60, 90, and 120 s were placed into 300-µl polyethylene microfuge
tubes containing silicone oil (100 µl of density 1.02 g/ml) atop 50 µl of 3 N NaOH. The tubes were centrifuged immediately for rapid
filtration of the cells through the silicone oil layer to sediment into
the lower alkaline layer. The radioactivities of the incubation
mixture, the supernatant (top layer), and the hepatocytes (residue)
were quantified by liquid scintillation counting (model 6800, Beckman Canada, Mississauga, ON).
Uptake of E1S.
For all studies, cell suspensions of 2 × 106 cells/ml of the regular, periportal, or
perivenous hepatocytes, preincubated at 37°C for 10 min, were added
mixtures of E1S,
[3H]E1S and
[14C]sucrose (an extracellular marker) to
result in E1S concentrations of 1 to 400 µM in
1.6 × 106 cells/ml. Samples (100 µl) were
retrieved at 15, 30, 45, and 60 s for centrifugation as described
above. The effect of estradiol 17
-glucuronide (50 µM) and the
diuretic bumetanide (200 µM) on E1S (50 µM)
uptake was also studied. The inhibitory effect of pregnenolone sulfate
(0, 10, 25, and 100 µM) on the uptake of E1S (1 to 200 µM) was investigated in parallel incubations. Because 1%
ethanol was used for dissolution of pregnenolone sulfate in these
studies, cell viability and uptake of estrone sulfate in 0% and 1%
ethanol were first compared. Cell viability in 1% ethanol remained
greater than 90% for at least 15 min, as determined by trypan blue
exclusion. The preservation of hepatocytic viability in 1% ethanol was
also observed by Sawyer et al. (1994)
who demonstrated that both the
liver cell viability and respiratory function were not adversely
affected by 1% ethanol over a period of 6 h. In another set of
studies, parallel incubations were conducted in the presence or absence
of sodium
choline chloride was substituted for sodium chloride and
potassium bicarbonate for sodium bicarbonate.
Kinetic Analysis of E1S Uptake.
The linear portion of the plot of accumulated amount versus time
yielded a positive intercept and a slope on regression of the data. The
positive intercept that represents rapid and saturable binding of
E1S to hepatocyte membrane had been described by
Hassen et al. (1996)
. The slope furnished the initial velocity of
uptake (v).
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
(5) |
|
(6) |
|
(7) |
|
(8) |
|
(9) |
Fitting. The data were fitted with use of the software package SCIENTIST (version 2; MicroMath Scientific Software, Salt Lake City, UT) with the least-squares method. The optimized parameters are summarized in Tables 1 to 4. The selection of the weighting scheme and goodness of fit were based on the coefficients of variation of the estimated parameters and residual plots.
Statistical Analysis.
All data were presented as the mean ± S.D. and the means were
compared by use of ANOVA, with the level of significance set at .05. The Model Selection Criterion and the Akaike Information Criteria
(Akaike, 1974
; Ludden et al., 1994
) were used to select the appropriate
model equation(s).
| |
Results |
|---|
|
|
|---|
Biochemical Characterization of Zonal Hepatocytes. The activities of the two marker enzymes, alanine aminotransferase and glutamine synthetase, in the periportal and perivenous hepatocytes are summarized in Table 1. Significant difference (p < .05, ANOVA) was observed among the periportal and perivenous hepatocytes.
|
|
Uptake Kinetics of E1S.
The time course for the uptake of E1S was shown
in Fig. 2. Accumulation of
E1S in hepatocytes remained linear with time
within 1 min for all of the concentrations of E1S
(1 to 400 µM). When the velocity was plotted against the
E1S concentration, concentration-dependent kinetics became evident (Fig. 3A).
Moreover, transport was temperature dependent and was reduced to a
constant value (clearance of 2.1 ± 0.2 µl/min/mg protein) at
4°C. The data were best described by eq. 2, as found by Hassen et al.
(1996)
, and a weighting scheme of 1/observation was optimal for
fitting. The uptake of E1S was not significantly
different among regular, periportal, and perivenous hepatocytes (Fig.
3B; ANOVA, p > .05, table
2). The Kms
and Vmaxs varied from 24 to 26 µM and 1.8 nmol/min/mg protein, respectively, and the linear clearance,
Pdiff, was 2.5 to 3.2 µl/min/mg protein. These kinetic constants were generally similar to those found by Hassen
et al. (1996)
, but differed from those of Schwenk and del Pino (1980)
,
who examined a much lower concentration range (0.1 to 10 µM) to
arrive at lower estimates (Km of 0.8 µM
and Vmax of 0.3 nmol/min/mg protein).
|
|
|
Uptake of E1S in Presence of Inhibitors.
Previous studies had shown inhibition of E1S
uptake by ouabain, energy depletors, and other sulfate conjugates
(Hassen et al., 1996
), as well as by taurocholate (Schwenk and del
Pino, 1980
). Presently, the coadministration of estradiol
17
-glucuronide (50 µM) and bumetanide (200 µM) was found to
reduce E1S (50 µM) uptake significantly (to
66 ± 5.2% and 64 ± 3.5% of control, respectively, n = 4, p < .05). The uptake of
E1S in the presence and absence of 1% ethanol
was best described by eq. 2. Upon comparison, the saturable component
of E1S transport in the presence and absence of
1% ethanol was similar, but the nonsaturable component of the uptake
of E1S was slightly higher in the presence of
ethanol (Fig. 4A and Table
3). The reason for the difference was not
apparent. When the effect of pregnenolone sulfate (0, 10, 25, and 100 µM dissolved in 1% ethanol) on E1S uptake was
examined in parallel incubations, the extent of inhibition intensified
with increasing concentration of pregnenolone sulfate. The data were
best fitted to the competitive inhibition equation (eq. 5, Table
4); the overall inhibition constant was
6.7 µM, a value that is less than the overall
Km for E1S uptake
(cf. values in Tables 2 and 3).
|
|
|
Uptake of E1S in Presence and Absence of Sodium. The uptake parameters for E1S by rat hepatocytes were significantly reduced in absence of sodium (Fig. 5A and Table 4, p < .05, ANOVA). Similar values as well as trends were observed for the data for periportal and perivenous hepatocytes in absence of sodium (Fig. 5B). The data were best fitted simultaneously to eqs. 4 and 2, which described two saturable systems and a nonsaturable component, instead of eqs. 5 and 3 due to the greater Model Selection Criterion, lower Akaike Information Criteria values, and the smaller coefficient of variation. These "refined" uptake parameters, summarized in Table 4, revealed a slightly higher affinity (Km of 16 to 22 µM) and slightly lower capacity (Vmax of 0.70 to 0.84 nmol/min/mg protein) system for the sodium-independent component, a lower affinity (Km of 49 to 55 µM) and slightly higher capacity (Vmax of 1.1 to 1.4 nmol/min/mg protein) system for the sodium-dependent component, and a linear component (Pdiff of 1.7 to 2.7 µl/min/mg protein).
|
| |
Discussion |
|---|
|
|
|---|
The marker enzymes, alanine aminotransferase and glutamine
synthetase, verified that enriched periportal and perivenous
hepatocytes were isolated from different lobular origin within the rat
liver. Our finding that alanine aminotransferase activity was higher in
periportal hepatocytes (with a ratio of 1.9 for periportal to
perivenous activities, Table 1) was in agreement with histochemical evidence on the enzyme in rat liver (Gorgens et al., 1988
) and what was
observed in other studies (Sillau et al., 1996
; Tosh et al., 1996
). The
dramatic difference in glutamine synthetase activity between the
perivenous and periportal regions (Table 1) was also shown by Stoll et
al. (1991)
and provided evidence on the successful preparation of
enriched populations of periportal and perivenous cells. In addition,
glutamate uptake, mediated by the sodium-dependent transporter, System
G, in the perivenous region (Stoll et al., 1991
) as well as the
sodium-independent system in both periportal and perivenous hepatocytes
(Burger et al., 1989
; Stoll et al., 1991
) was higher in perivenous
hepatocytes (Fig. 1).
Although heterogeneity in transport was found for many endogenous and
exogenous compounds: taurocholate (Stacey and Klaassen, 1981
), ouabain
(Stacey and Klaassen, 1981
), and cysteine (Saiki et al., 1992
), no
significant difference in the uptake of E1S was
found among the regular, periportal and perivenous hepatocytes. Among
these systems, E1S uptake is described by a
saturable and nonsaturable system of similar magnitudes (Table 2). The
constancy in the values of Pdiff among the
data sets in both the absence and presence of sodium suggests that
Pdiff is most likely passive diffusion,
because a relatively high diffusive component could be predicted for
E1S in view of its high (1.4) octanol/water
partition at pH 7.4 (our unpublished data). However, the
discrepancy in the nonsaturable component of E1S
uptake, Pdiff, in the presence of 1%
ethanol may due to the fitting anomaly; the concentration used for this
study was lower (up to 200 µM) and might not be high enough to fully
reveal the linear component. In addition to the previously found
inhibitors (Schwenk and del Pino, 1980
; Hassen et al., 1996
), the
transport of E1S was reduced by estradiol 17
-glucuronide, a high-affinity substrate for oatp1 (Kanai et al.,
1996
), and bumetanide, a substrate for an organic anion transporter distinct from oatp1 and Ntcp (Horz et al., 1996
), and was strongly inhibited by pregnenolone sulfate in a competitive fashion (Table 3 and
Fig. 4).
Because oatp1, oatp2, and Ntcp mediate the transport of
E1S in rat liver, it is reasonable to assume that
data obtained with sodium-free media represent uptake by oatp1 and/or
oatp2, the sodium-independent transporter, whereas data obtained in the
presence of sodium encompass the entire spectrum of transporters in
liver, including Ntcp. Thus, simultaneous fitting of data obtained in the presence and absence of sodium to eqs. 4 and 2, respectively, yielded the best model. The hepatocellular entry of
E1S was best described by three components: a
sodium-dependent component (saturable component), a sodium-independent
component (saturable component), and a nonsaturable or linear component
(Fig. 5 and Table 4). Furthermore, uptake of E1S
by both sodium-dependent or -independent systems was not significantly
different among the periportal and perivenous hepatocytes (Table 4).
This finding was in agreement with immunohistochemical evidence for
Ntcp (Stieger et al., 1994
) and for oatp1 in isolated, zonal
hepatocytes (T. N. Abu-Zahra, A.W. Wolkoff, and K. S. Pang,
unpublished observations).
In this investigation, the Kms of the
E1S transporters in rat hepatocytes were 14 and
47 µM, respectively, for the sodium-independent and -dependent
system, suggesting that the sodium-independent pathway is of higher
affinity. Indeed, transporters found in the rat liver, namely, oatp1
(Bossuyt et al., 1996
), oatp2 (Noé et al., 1997
), and Ntcp
(Schroeder et al., 1998
) expressed in the Xenopus laevis
oocytes mediate the transport of E1S with
corresponding Kms of 4.5, 11, and 27 µM,
respectively, whereas the Km for the uptake
of E1S uptake in COS cells expressing the
human liver NTCP is 60 µM (Craddock et al., 1998
). A low
Km for E1S was
inferred in the inhibition of studies of E1S on
estradiol 17
-glucuronide transport (Kanai et al., 1996
). It
appears that the Kms obtained from rat
hepatocytes in this study correlate well with those obtained in other
expression systems and that separation of the contributions of oatp1
and oatp2 for the transport of E1S was not
feasible, because the Kms are close in
values. The observation supports the view that, in absence of
perturbation of the system and proper modeling, it becomes extremely
difficult to separate the respective saturable components when the
Kms are similar (Sedman and Wagner, 1974
).
It is further interesting to note that the sum of the
Vmaxs of the two saturable systems (Table
4) was similar to the overall Vmax obtained
when data were treated as if it were a single saturable system (Table
2). Analogously, the Kms of the two
saturable systems (Table 4), when averaged, matched the overall
Km obtained when data were treated as if it
were a single saturable system (Table 2).
In conclusion, two saturable systems, a sodium-dependent and a sodium-independent system that most likely represent Ntcp and oatp, respectively, and a linear system, were found to mediate the transport of estrone sulfate. There was no difference in the uptake of E1S among regular, periportal, and perivenous hepatocytes. Pregnenolone sulfate was found to competitively inhibit the transport of E1S in rat liver.
| |
Footnotes |
|---|
Received October 15, 1998; accepted December 16, 1998.
This work was supported by the National Institutes of Health (Grant GM-38250) and Medical Research Council of Canada (MA-9104). Eugene Tan was a recipient of the Medical Research Council of Canada graduate fellowship.
Send reprint requests to: Dr. K.S. Pang, Faculty of Pharmacy, University of Toronto, 19 Russell St., Toronto, Ontario, Canada M5S 2S2. E-mail: pang{at}phm.utoronto.ca
| |
Abbreviations |
|---|
Abbreviations used are: E1S, estrone sulfate; oatp1 and oatp2, organic anion transporting polypeptide 1 and 2; Ntcp, sodium-dependent taurocholate cotransporting polypeptide.
| |
References |
|---|
|
|
|---|
-D-glucuronide is a high affinity substrate for oatp organic anion transporter.
Am J Physiol
270:
F326-F331This article has been cited by other articles:
![]() |
T. Nozawa, M. Suzuki, K. Takahashi, H. Yabuuchi, T. Maeda, A. Tsuji, and I. Tamai Involvement of Estrone-3-Sulfate Transporters in Proliferation of Hormone-Dependent Breast Cancer Cells J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1032 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Houle, J. Raoul, J.-F. Levesque, K. S. Pang, D. A. Nicoll-Griffith, and J. M. Silva Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes Drug Metab. Dispos., April 1, 2003; 31(4): 447 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Schwab, L. Tao, M. Kang, L. Meng, and K. S. Pang Moment Analysis of Metabolic Heterogeneity: Conjugation of Benzoate with Glycine in Rat Liver Studied by Multiple Indicator Dilution Technique J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 279 - 289. [Abstract] [Full Text] |
||||
![]() |
E. Tan, T. Lu, and K. S. Pang Futile Cycling of Estrone Sulfate and Estrone in the Recirculating Perfused Rat Liver Preparation J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 423 - 436. [Abstract] [Full Text] |
||||
![]() |
E. Tan and K. S. Pang Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes Drug Metab. Dispos., March 1, 2001; 29(3): 335 - 346. [Abstract] [Full Text] |
||||
![]() |
T. N. Abu-Zahra, A. W. Wolkoff, R. B. Kim, and K. S. Pang Uptake of Enalapril and Expression of Organic Anion Transporting Polypeptide 1 in Zonal, Isolated Rat Hepatocytes Drug Metab. Dispos., July 1, 2000; 28(7): 801 - 806. [Abstract] [Full Text] |
||||
![]() |
T. N. Abu-Zahra and K. S. Pang Effect of Zonal Transport and Metabolism on Hepatic Removal: Enalapril Hydrolysis in Zonal, Isolated Rat Hepatocytes In Vitro and Correlation with Perfusion Data Drug Metab. Dispos., July 1, 2000; 28(7): 807 - 813. [Abstract] [Full Text] |
||||
![]() |
R. G. Tirona, E. Tan, G. Meier, and K. S. Pang Uptake and Glutathione Conjugation of Ethacrynic Acid and Efflux of the Glutathione Adduct by Periportal and Perivenous Rat Hepatocytes J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1210 - 1219. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||